Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 234

1.

A review of the diagnosis and management of vertebral basilar (posterior) circulation disease.

Ausman JI, Liebeskind DS, Gonzalez N, Saver J, Martin N, Villablanca JP, Vespa P, Duckwiler G, Jahan R, Niu T, Salamon N, Yoo B, Tateshima S, Buitrago Blanco MM, Starkman S.

Surg Neurol Int. 2018 May 24;9:106. doi: 10.4103/sni.sni_373_17. eCollection 2018. Review.

2.

Abnormal Trajectory of Intracortical Myelination in Schizophrenia Implicates White Matter in Disease Pathophysiology and the Therapeutic Mechanism of Action of Antipsychotics.

Tishler TA, Bartzokis G, Lu PH, Raven EP, Khanoyan M, Kirkpatrick CJ, Pyle MH, Villablanca JP, Altshuler LL, Mintz J, Ventura J, Casaus LR, Subotnik KL, Nuechterlein KH, Ellingson BM.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 May;3(5):454-462. doi: 10.1016/j.bpsc.2017.03.007. Epub 2017 Mar 14.

PMID:
29735155
3.

Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.

Pinto N, DuBois SG, Marachelian A, Diede SJ, Taraseviciute A, Glade Bender JL, Tsao-Wei D, Groshen SG, Reid JM, Haas-Kogan DA, Reynolds CP, Kang MH, Irwin MS, Macy ME, Villablanca JG, Matthay KK, Park JR.

Pediatr Blood Cancer. 2018 Jul;65(7):e27023. doi: 10.1002/pbc.27023. Epub 2018 Mar 30.

4.

Early Blood-Brain Barrier Disruption after Mechanical Thrombectomy in Acute Ischemic Stroke.

Shi ZS, Duckwiler GR, Jahan R, Tateshima S, Szeder V, Saver JL, Kim D, Sharma LK, Vespa PM, Salamon N, Villablanca JP, Viñuela F, Feng L, Loh Y, Liebeskind DS.

J Neuroimaging. 2018 May;28(3):283-288. doi: 10.1111/jon.12504. Epub 2018 Feb 27.

PMID:
29484769
5.

Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.

Villablanca JG, Ji L, Shapira-Lewinson A, Marachelian A, Shimada H, Hawkins RA, Pampaloni M, Lai H, Goodarzian F, Sposto R, Park JR, Matthay KK.

Pediatr Blood Cancer. 2018 May;65(5):e26940. doi: 10.1002/pbc.26940. Epub 2018 Jan 19.

PMID:
29350464
6.

Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.

Marachelian A, Villablanca JG, Liu CW, Liu B, Goodarzian F, Lai HA, Shimada H, Tran HC, Parra JA, Gallego R, Bedrossian N, Young S, Czarnecki S, Kennedy R, Weiss BD, Goldsmith K, Granger M, Matthay KK, Groshen S, Asgharzadeh S, Sposto R, Seeger RC.

Clin Cancer Res. 2017 Sep 15;23(18):5374-5383. doi: 10.1158/1078-0432.CCR-16-2647. Epub 2017 May 30.

PMID:
28559462
7.

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, Burchill S, Boubaker A, McHugh K, Nuchtern JG, London WB, Seibel NL, Lindwasser OW, Maris JM, Brock P, Schleiermacher G, Ladenstein R, Matthay KK, Valteau-Couanet D.

J Clin Oncol. 2017 Aug 1;35(22):2580-2587. doi: 10.1200/JCO.2016.72.0177. Epub 2017 May 4. Review.

8.

Radiographic and Magnetic Resonance Imaging Identification of Thoracolumbar Spine Variants with Implications for the Positioning of the Conus Medullaris in Rhesus Macaques.

Ohlsson M, Nieto JH, Christe KL, Villablanca JP, Havton LA.

Anat Rec (Hoboken). 2017 Feb;300(2):300-308. doi: 10.1002/ar.23495. Epub 2016 Nov 7.

9.

Utilization of Emergent Neuroimaging for Thrombolysis-Eligible Stroke Patients.

Sanossian N, Fu KA, Liebeskind DS, Starkman S, Hamilton S, Villablanca JP, Burgos AM, Conwit R, Saver JL.

J Neuroimaging. 2017 Jan;27(1):59-64. doi: 10.1111/jon.12369. Epub 2016 Jun 14.

10.

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.

Villablanca JG, Volchenboum SL, Cho H, Kang MH, Cohn SL, Anderson CP, Marachelian A, Groshen S, Tsao-Wei D, Matthay KK, Maris JM, Hasenauer CE, Czarnecki S, Lai H, Goodarzian F, Shimada H, Reynolds CP.

Pediatr Blood Cancer. 2016 Aug;63(8):1349-56. doi: 10.1002/pbc.25994. Epub 2016 Apr 19.

PMID:
27092812
11.

New Cerebral Microbleeds After Mechanical Thrombectomy for Large-Vessel Occlusion Strokes.

Shi ZS, Duckwiler GR, Jahan R, Tateshima S, Gonzalez NR, Szeder V, Saver JL, Kim D, Ali LK, Starkman S, Vespa PM, Salamon N, Villablanca JP, Viñuela F, Feng L, Loh Y, Liebeskind DS.

Medicine (Baltimore). 2015 Nov;94(47):e2180. doi: 10.1097/MD.0000000000002180.

12.

Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).

Zhou MJ, Doral MY, DuBois SG, Villablanca JG, Yanik GA, Matthay KK.

Eur J Cancer. 2015 Nov;51(16):2465-72. doi: 10.1016/j.ejca.2015.07.023. Epub 2015 Aug 5.

13.

Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.

Anderson CP, Matthay KK, Perentesis JP, Neglia JP, Bailey HH, Villablanca JG, Groshen S, Hasenauer B, Maris JM, Seeger RC, Reynolds CP.

Pediatr Blood Cancer. 2015 Oct;62(10):1739-46. doi: 10.1002/pbc.25594. Epub 2015 Jul 7.

PMID:
26153194
14.

Mechanical thrombectomy for acute ischemic stroke with cerebral microbleeds.

Shi ZS, Duckwiler GR, Jahan R, Tateshima S, Gonzalez NR, Szeder V, Saver JL, Kim D, Ali LK, Starkman S, Vespa PM, Salamon N, Villablanca JP, Viñuela F, Feng L, Loh Y, Liebeskind DS.

J Neurointerv Surg. 2016 Jun;8(6):563-7. doi: 10.1136/neurintsurg-2015-011765. Epub 2015 May 20.

PMID:
25994939
15.

Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.

DuBois SG, Groshen S, Park JR, Haas-Kogan DA, Yang X, Geier E, Chen E, Giacomini K, Weiss B, Cohn SL, Granger MM, Yanik GA, Hawkins R, Courtier J, Jackson H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Villablanca JG, Marachelian A, Matthay KK.

Clin Cancer Res. 2015 Jun 15;21(12):2715-21. doi: 10.1158/1078-0432.CCR-14-3240. Epub 2015 Feb 18.

16.

131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study.

Yanik GA, Villablanca JG, Maris JM, Weiss B, Groshen S, Marachelian A, Park JR, Tsao-Wei D, Hawkins R, Shulkin BL, Jackson H, Goodarzian F, Shimada H, Courtier J, Hutchinson R, Haas-Koga D, Hasenauer CB, Czarnecki S, Katzenstein HM, Matthay KK.

Biol Blood Marrow Transplant. 2015 Apr;21(4):673-81. doi: 10.1016/j.bbmt.2014.12.008. Epub 2015 Jan 30.

17.

Bayesian estimation of cerebral perfusion using reduced-contrast-dose dynamic susceptibility contrast perfusion at 3T.

Nael K, Mossadeghi B, Boutelier T, Kubal W, Krupinski EA, Dagher J, Villablanca JP.

AJNR Am J Neuroradiol. 2015 Apr;36(4):710-8. doi: 10.3174/ajnr.A4184. Epub 2014 Nov 27.

18.

Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.

Kang MH, Villablanca JG, Glade Bender JL, Matthay KK, Groshen S, Sposto R, Czarnecki S, Ames MM, Reynolds CP, Marachelian A, Maurer BJ.

BMC Res Notes. 2014 Apr 23;7:256. doi: 10.1186/1756-0500-7-256.

19.

Combined low-dose contrast-enhanced MR angiography and perfusion for acute ischemic stroke at 3T: A more efficient stroke protocol.

Nael K, Meshksar A, Ellingson B, Pirastehfar M, Salamon N, Finn P, Liebeskind DS, Villablanca JP.

AJNR Am J Neuroradiol. 2014 Jun;35(6):1078-84. doi: 10.3174/ajnr.A3848. Epub 2014 Feb 6.

20.

Accelerated echo-planar J-resolved spectroscopic imaging in the human brain using compressed sensing: a pilot validation in obstructive sleep apnea.

Sarma MK, Nagarajan R, Macey PM, Kumar R, Villablanca JP, Furuyama J, Thomas MA.

AJNR Am J Neuroradiol. 2014 Jun;35(6 Suppl):S81-9. doi: 10.3174/ajnr.A3846. Epub 2014 Feb 6.

21.

Role of EPI-FLAIR in patients with acute stroke: a comparative analysis with FLAIR.

Meshksar A, Villablanca JP, Khan R, Carmody R, Coull B, Nael K.

AJNR Am J Neuroradiol. 2014 May;35(5):878-83. doi: 10.3174/ajnr.A3786. Epub 2013 Dec 12.

22.

Estimating peak skin and eye lens dose from neuroperfusion examinations: use of Monte Carlo based simulations and comparisons to CTDIvol, AAPM Report No. 111, and ImPACT dosimetry tool values.

Zhang D, Cagnon CH, Villablanca JP, McCollough CH, Cody DD, Zankl M, Demarco JJ, McNitt-Gray MF.

Med Phys. 2013 Sep;40(9):091901. doi: 10.1118/1.4816652.

23.

Quantitative analysis of hypoperfusion in acute stroke: arterial spin labeling versus dynamic susceptibility contrast.

Nael K, Meshksar A, Liebeskind DS, Coull BM, Krupinski EA, Villablanca JP.

Stroke. 2013 Nov;44(11):3090-6. doi: 10.1161/STROKEAHA.113.002377. Epub 2013 Aug 29.

24.

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.

Kreissman SG, Seeger RC, Matthay KK, London WB, Sposto R, Grupp SA, Haas-Kogan DA, Laquaglia MP, Yu AL, Diller L, Buxton A, Park JR, Cohn SL, Maris JM, Reynolds CP, Villablanca JG.

Lancet Oncol. 2013 Sep;14(10):999-1008. doi: 10.1016/S1470-2045(13)70309-7. Epub 2013 Jul 25.

25.

Natural history of asymptomatic unruptured cerebral aneurysms evaluated at CT angiography: growth and rupture incidence and correlation with epidemiologic risk factors.

Villablanca JP, Duckwiler GR, Jahan R, Tateshima S, Martin NA, Frazee J, Gonzalez NR, Sayre J, Vinuela FV.

Radiology. 2013 Oct;269(1):258-65. doi: 10.1148/radiol.13121188. Epub 2013 Jul 2.

26.

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.

Maurer BJ, Kang MH, Villablanca JG, Janeba J, Groshen S, Matthay KK, Sondel PM, Maris JM, Jackson HA, Goodarzian F, Shimada H, Czarnecki S, Hasenauer B, Reynolds CP, Marachelian A.

Pediatr Blood Cancer. 2013 Nov;60(11):1801-8. doi: 10.1002/pbc.24643. Epub 2013 Jun 29.

27.

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.

Yanik GA, Parisi MT, Shulkin BL, Naranjo A, Kreissman SG, London WB, Villablanca JG, Maris JM, Park JR, Cohn SL, McGrady P, Matthay KK.

J Nucl Med. 2013 Apr;54(4):541-8. doi: 10.2967/jnumed.112.112334. Epub 2013 Feb 25.

28.

Periprocedural arterial spin labeling and dynamic susceptibility contrast perfusion in detection of cerebral blood flow in patients with acute ischemic syndrome.

Nael K, Meshksar A, Liebeskind DS, Wang DJ, Ellingson BM, Salamon N, Villablanca JP; UCLA Stroke investigators.

Stroke. 2013 Mar;44(3):664-70. doi: 10.1161/STROKEAHA.112.672956. Epub 2013 Feb 6.

29.

Feasibility of placement of an anterior cervical epidural blood patch for spontaneous intracranial hypotension.

Park JK, Villablanca JP.

AJNR Am J Neuroradiol. 2013 Aug;34(8):E84-6. doi: 10.3174/ajnr.A3244. Epub 2012 Oct 11.

30.

Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma.

Asgharzadeh S, Salo JA, Ji L, Oberthuer A, Fischer M, Berthold F, Hadjidaniel M, Liu CW, Metelitsa LS, Pique-Regi R, Wakamatsu P, Villablanca JG, Kreissman SG, Matthay KK, Shimada H, London WB, Sposto R, Seeger RC.

J Clin Oncol. 2012 Oct 1;30(28):3525-32. Epub 2012 Aug 27.

31.

Acute stroke: a comparison of different CT perfusion algorithms and validation of ischaemic lesions by follow-up imaging.

Abels B, Villablanca JP, Tomandl BF, Uder M, Lell MM.

Eur Radiol. 2012 Dec;22(12):2559-67. doi: 10.1007/s00330-012-2529-8. Epub 2012 Jun 21.

PMID:
22717727
32.

Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.

Matthay KK, Weiss B, Villablanca JG, Maris JM, Yanik GA, Dubois SG, Stubbs J, Groshen S, Tsao-Wei D, Hawkins R, Jackson H, Goodarzian F, Daldrup-Link H, Panigrahy A, Towbin A, Shimada H, Barrett J, Lafrance N, Babich J.

J Nucl Med. 2012 Jul;53(7):1155-63. doi: 10.2967/jnumed.111.098624. Epub 2012 Jun 14. Erratum in: J Nucl Med. 2016 Jun;57(6):988.

33.

The hyperdense vessel sign on CT predicts successful recanalization with the Merci device in acute ischemic stroke.

Froehler MT, Tateshima S, Duckwiler G, Jahan R, Gonzalez N, Vinuela F, Liebeskind D, Saver JL, Villablanca JP; UCLA Stroke Investigators.

J Neurointerv Surg. 2013 Jul;5(4):289-93. doi: 10.1136/neurintsurg-2012-010313. Epub 2012 May 22.

34.

The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.

Marachelian A, Shimada H, Sano H, Jackson H, Stein J, Sposto R, Matthay KK, Baker D, Villablanca JG.

Pediatr Blood Cancer. 2012 May;58(5):675-81.

PMID:
22493777
35.

Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial.

DuBois SG, Chesler L, Groshen S, Hawkins R, Goodarzian F, Shimada H, Yanik G, Tagen M, Stewart C, Mosse YP, Maris JM, Tsao-Wei D, Marachelian A, Villablanca JG, Matthay KK.

Clin Cancer Res. 2012 May 1;18(9):2679-86. doi: 10.1158/1078-0432.CCR-11-3201. Epub 2012 Mar 15.

36.

Peak skin and eye lens radiation dose from brain perfusion CT based on Monte Carlo simulation.

Zhang D, Cagnon CH, Villablanca JP, McCollough CH, Cody DD, Stevens DM, Zankl M, Demarco JJ, Turner AC, Khatonabadi M, McNitt-Gray MF.

AJR Am J Roentgenol. 2012 Feb;198(2):412-7. doi: 10.2214/AJR.11.7230.

37.

Association of laterality and size of perfusion lesions on neurological deficit in acute supratentorial stroke.

Lee M, Saver JL, Alger JR, Hao Q, Salamon N, Starkman S, Ali LK, Ovbiagele B, Kim D, Villablanca JP, Froehler MT, Tenser MS, Liebeskind DS.

Int J Stroke. 2012 Jun;7(4):293-7. doi: 10.1111/j.1747-4949.2011.00726.x. Epub 2011 Dec 8.

38.

Diffusion-weighted imaging of malignant ocular masses: initial results and directions for further study.

Sepahdari AR, Kapur R, Aakalu VK, Villablanca JP, Mafee MF.

AJNR Am J Neuroradiol. 2012 Feb;33(2):314-9. doi: 10.3174/ajnr.A2747. Epub 2011 Nov 24.

39.

Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010.

Gozali AE, Britt B, Shane L, Gonzalez I, Gilles F, McComb JG, Krieger MD, Lavey RS, Shlien A, Villablanca JG, Erdreich-Epstein A, Dhall G, Jubran R, Tabori U, Malkin D, Finlay JL.

Pediatr Blood Cancer. 2012 Jun;58(6):905-9. doi: 10.1002/pbc.23349. Epub 2011 Oct 11.

PMID:
21990040
40.

Wall shear stress distribution inside growing cerebral aneurysm.

Tanoue T, Tateshima S, Villablanca JP, Viñuela F, Tanishita K.

AJNR Am J Neuroradiol. 2011 Oct;32(9):1732-7. doi: 10.3174/ajnr.A2607.

41.

Blood-brain barrier permeability derangements in posterior circulation ischemic stroke: frequency and relation to hemorrhagic transformation.

Lee M, Saver JL, Alger JR, Hao Q, Starkman S, Ali LK, Kim D, Ovbiagele B, Vespa PM, Froehler MT, Tenser MS, Salamon N, Villablanca JP, Jahan R, Duckwiler GR, Tateshima S, Gonzalez N, Vinuela F, Liebeskind DS.

J Neurol Sci. 2012 Feb 15;313(1-2):142-6. doi: 10.1016/j.jns.2011.08.048. Epub 2011 Sep 25.

42.

Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.

Villablanca JG, London WB, Naranjo A, McGrady P, Ames MM, Reid JM, McGovern RM, Buhrow SA, Jackson H, Stranzinger E, Kitchen BJ, Sondel PM, Parisi MT, Shulkin B, Yanik GA, Cohn SL, Reynolds CP.

Clin Cancer Res. 2011 Nov 1;17(21):6858-66. doi: 10.1158/1078-0432.CCR-11-0995. Epub 2011 Sep 9.

43.

CT perfusion in acute ischemic stroke: a comparison of 2-second and 1-second temporal resolution.

Abels B, Klotz E, Tomandl BF, Villablanca JP, Kloska SP, Lell MM.

AJNR Am J Neuroradiol. 2011 Oct;32(9):1632-9. doi: 10.3174/ajnr.A2576. Epub 2011 Aug 4.

44.

A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.

Russell HV, Groshen SG, Ara T, DeClerck YA, Hawkins R, Jackson HA, Daldrup-Link HE, Marachelian A, Skerjanec A, Park JR, Katzenstein H, Matthay KK, Blaney SM, Villablanca JG.

Pediatr Blood Cancer. 2011 Aug;57(2):275-82. doi: 10.1002/pbc.22821. Epub 2010 Nov 12.

45.

CT and MRI early vessel signs reflect clot composition in acute stroke.

Liebeskind DS, Sanossian N, Yong WH, Starkman S, Tsang MP, Moya AL, Zheng DD, Abolian AM, Kim D, Ali LK, Shah SH, Towfighi A, Ovbiagele B, Kidwell CS, Tateshima S, Jahan R, Duckwiler GR, Viñuela F, Salamon N, Villablanca JP, Vinters HV, Marder VJ, Saver JL.

Stroke. 2011 May;42(5):1237-43. doi: 10.1161/STROKEAHA.110.605576. Epub 2011 Mar 10.

46.

Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.

Minturn JE, Evans AE, Villablanca JG, Yanik GA, Park JR, Shusterman S, Groshen S, Hellriegel ET, Bensen-Kennedy D, Matthay KK, Brodeur GM, Maris JM.

Cancer Chemother Pharmacol. 2011 Oct;68(4):1057-65. doi: 10.1007/s00280-011-1581-4. Epub 2011 Feb 22.

47.

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.

Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM; Children's Oncology Group.

N Engl J Med. 2010 Sep 30;363(14):1324-34. doi: 10.1056/NEJMoa0911123.

48.

Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.

Quach A, Ji L, Mishra V, Sznewajs A, Veatch J, Huberty J, Franc B, Sposto R, Groshen S, Wei D, Fitzgerald P, Maris JM, Yanik G, Hawkins RA, Villablanca JG, Matthay KK.

Pediatr Blood Cancer. 2011 Feb;56(2):191-201. doi: 10.1002/pbc.22767. Epub 2010 Sep 9.

49.

Resuscitation after prolonged cardiac arrest: role of cardiopulmonary bypass and systemic hyperkalemia.

Liakopoulos OJ, Allen BS, Buckberg GD, Hristov N, Tan Z, Villablanca JP, Trummer G.

Ann Thorac Surg. 2010 Jun;89(6):1972-9. doi: 10.1016/j.athoracsur.2010.02.052.

PMID:
20494058
50.

Why do we have a caudate nucleus?

Villablanca JR.

Acta Neurobiol Exp (Wars). 2010;70(1):95-105. Review.

Supplemental Content

Loading ...
Support Center